首页>
外国专利>
combination of cis - 4 - hydroxy l proline and n - methyl - cis - 4 - hydroxy l proline for use as therapeutic agent in cancer therapy
combination of cis - 4 - hydroxy l proline and n - methyl - cis - 4 - hydroxy l proline for use as therapeutic agent in cancer therapy
展开▼
机译:顺-4-羟基脯氨酸和正甲基-顺-4-羟基脯氨酸的组合用作癌症治疗中的治疗剂;
展开▼
页面导航
摘要
著录项
相似文献
摘要
PCT No. PCT/DE97/00486 Sec. 371 Date Sep. 9, 1998 Sec. 102(e) Date Sep. 9, 1998 PCT Filed Mar. 11, 1997 PCT Pub. No. WO97/33578 PCT Pub. Date Sep. 18, 1997The disclosure relates to a combination of cis-4-hydroxy-L-proline and n-methyl-cis-4-hydroxy-L-proline for use as a therapeutic agent, in particular in cancer treatment. Also disclosed is the use of the individual substances for treating hormone-sensitive prostate cancer.
展开▼